Literature DB >> 25337276

Evaluation of serum anti-Mullerian hormone as a biomarker of early ovarian aging in young women undergoing IVF/ICSI cycle.

Pin-Yao Lin1, Fu-Jen Huang1, Fu-Tsai Kung1, Hsin-Ju Chiang1, Yu-Ju Lin1, Yi-Chi Lin1, Kuo-Chung Lan1.   

Abstract

OBJECTIVE: To determine whether or not the level of serum anti-Müllerian hormone (AMH) is related to early ovarian aging in young women (< 35 years of age) undergoing in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) cycles.
DESIGN: Retrospective cohort study.
SETTING: An IVF laboratory in a university hospital in Taiwan. Patient (s): 70 young women (< 35 years of age) with low level of serum AMH (< 2 ng/ml) and 104 young women with level of serum AMH (≥ 2 ng/ml) who underwent IVF/ICSI cycles between January 2011 and November 2012 were enrolled. Intervention (s): None. Main outcome measure (s): Number of oocytes, fertilization rate, embryo quality, cycle cancellation rate, clinical pregnancy/abortion rate, and perinatal/infant outcomes.
RESULTS: The clinical pregnancy rate per transfer was favorable (low AMH group vs. normal AMH group [47.2% and 47.9%]) for women < 35 years of age, including women with a low serum AMH. Similarly, the live birth rate per transfer (low AMH group vs. normal AMH group [37.7% and 35.4%]) and perinatal outcomes were also comparable between the two groups. A significantly higher cycle cancellation was noted in the low AMH group than the normal AMH group (24.2% vs. 7.6%).
CONCLUSION: Although early ovarian aging should be taken into consideration for young and infertile women with low AMH level than expected, our results suggest that low serum AMH level may suggest early ovarian aging in accelerated oocyte loss only, but may not fully represent "early ovarian aging" based on the favorable outcomes of pregnancy.

Entities:  

Keywords:  Anti-müllerian hormone; early ovarian aging; low ovarian reserve; perinatal outcomes; pregnancy outcomes

Mesh:

Substances:

Year:  2014        PMID: 25337276      PMCID: PMC4203247     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  35 in total

1.  Is premature ovarian ageing a cause of unexplained recurrent miscarriage?

Authors:  X Yuan; H Y Lin; Q Wang; T C Li
Journal:  J Obstet Gynaecol       Date:  2012-07       Impact factor: 1.246

2.  Normal serum anti-Müllerian hormone levels in the general female population and the relationship with reproductive history.

Authors:  Antonio La Marca; Elena Spada; Valentina Grisendi; Cindy Argento; Enrico Papaleo; Silvano Milani; Annibale Volpe
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2012-05-11       Impact factor: 2.435

3.  Anti-Mullerian hormone is a more accurate predictor of individual time to menopause than mother's age at menopause.

Authors:  M Dólleman; M Depmann; M J C Eijkemans; J Heimensem; S L Broer; E M van der Stroom; J S E Laven; I A J Van Rooij; G J Scheffer; P H M Peeters; Y T van der Schouw; C B Lambalk; F J M Broekmans
Journal:  Hum Reprod       Date:  2014-01-15       Impact factor: 6.918

4.  Young low responders protected from untoward effects of reduced ovarian response.

Authors:  J Hanoch; Y Lavy; H Holzer; A Hurwitz; A Simon; A Revel; N Laufer
Journal:  Fertil Steril       Date:  1998-06       Impact factor: 7.329

5.  Anti-Müllerian hormone (AMH): a reliable biomarker of oocyte quality in IVF.

Authors:  Pierre Lehmann; Maria P Vélez; Julio Saumet; Louise Lapensée; Wael Jamal; François Bissonnette; Simon Phillips; Isaac-Jacques Kadoch
Journal:  J Assist Reprod Genet       Date:  2014-02-27       Impact factor: 3.412

6.  Modeling age at menopause using serum concentration of anti-mullerian hormone.

Authors:  Fahimeh Ramezani Tehrani; Masoud Solaymani-Dodaran; Maryam Tohidi; Mahmood Reza Gohari; Fereidoun Azizi
Journal:  J Clin Endocrinol Metab       Date:  2013-01-11       Impact factor: 5.958

7.  Pregnancy prognosis in women with anti-Müllerian hormone below the tenth percentile.

Authors:  Aby Kottal Koshy; Anil Gudi; Amit Shah; Priya Bhide; Peter Timms; Roy Homburg
Journal:  Gynecol Endocrinol       Date:  2013-07       Impact factor: 2.260

8.  Value of antimüllerian hormone as a prognostic indicator of in vitro fertilization outcome.

Authors:  David E Reichman; Dan Goldschlag; Zev Rosenwaks
Journal:  Fertil Steril       Date:  2014-02-01       Impact factor: 7.329

Review 9.  Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications.

Authors:  Simone L Broer; Frank J M Broekmans; Joop S E Laven; Bart C J M Fauser
Journal:  Hum Reprod Update       Date:  2014-05-12       Impact factor: 15.610

Review 10.  The predictive accuracy of anti-Müllerian hormone for live birth after assisted conception: a systematic review and meta-analysis of the literature.

Authors:  Stamatina Iliodromiti; Thomas W Kelsey; Olivia Wu; Richard A Anderson; Scott M Nelson
Journal:  Hum Reprod Update       Date:  2014-02-13       Impact factor: 15.610

View more
  6 in total

1.  Prediction of ovarian aging using ovarian expression of BMP15, GDF9, and C-KIT.

Authors:  Min Jung Park; Jun-Woo Ahn; Ki Hyung Kim; Junghee Bang; Seung Chul Kim; Jae Yi Jeong; Ye Eun Choi; Chang-Woon Kim; Bo Sun Joo
Journal:  Exp Biol Med (Maywood)       Date:  2020-03-29

2.  The effect of blastomere loss during frozen embryo transfer on the transcriptome of offspring's umbilical cord blood.

Authors:  Yan-Ting Wu; Ze-Han Dong; Cheng Li; Dai-Zhan Zhou; Jun-Yu Zhang; Yan Wu; Jing-Jing Xu; Yu Wang; Xiao-Qun Ye; Jian-Zhong Sheng; Li Wang; He-Feng Huang
Journal:  Mol Biol Rep       Date:  2020-10-17       Impact factor: 2.316

3.  Long non-coding RNA HOTAIR overexpression improves premature ovarian failure by upregulating Notch-1 expression.

Authors:  Wei Zhao; Liwei Dong
Journal:  Exp Ther Med       Date:  2018-09-17       Impact factor: 2.447

4.  Prediction of different ovarian responses using anti-Müllerian hormone following a long agonist treatment protocol for IVF.

Authors:  Z Heidar; M Bakhtiyari; M Mirzamoradi; S Zadehmodarres; F S Sarfjoo; M A Mansournia
Journal:  J Endocrinol Invest       Date:  2015-05-17       Impact factor: 4.256

5.  Ovarian environment aging: follicular fluid lipidomic and related metabolic pathways.

Authors:  Fernanda Bertuccez Cordeiro; Daniela Antunes Montani; Eduardo Jorge Pilau; Fábio Cesar Gozzo; Renato Fraietta; Edson Guimaraes Lo Turco
Journal:  J Assist Reprod Genet       Date:  2018-07-16       Impact factor: 3.412

Review 6.  Developing a deeper insight into reproductive biomarkers.

Authors:  Braira Wahid; Hamid Bashir; Muhammad Bilal; Khansa Wahid; Aleena Sumrin
Journal:  Clin Exp Reprod Med       Date:  2017-12-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.